L773:1461 1457 OR L773:1469 5111
Sökning: L773:1461 1457 OR L773:1469 5111 > (2020-2024) > Making Sense of Pat...
LIBRIS Formathandbok (Information om MARC21)
| Fältnamn | Indikatorer | Metadata |
|---|---|---|
| 000 | 02662naa a2200313 4500 | |
| 001 | oai:prod.swepub.kib.ki.se:148072930 | |
| 003 | SwePub | |
| 008 | 240902s2021 | |||||||||||000 ||eng| | |
| 024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1480729302 URI |
| 024 | 7 | a https://doi.org/10.1093/ijnp/pyab0372 DOI |
| 040 | a (SwePub)ki | |
| 041 | a engb eng | |
| 042 | 9 SwePub | |
| 072 | 7 | a ref2 swepub-contenttype |
| 072 | 7 | a art2 swepub-publicationtype |
| 100 | 1 | a Unterholzner, J4 aut |
| 245 | 1 0 | a Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders |
| 264 | c 2021-07-03 | |
| 264 | 1 | b Oxford University Press (OUP),c 2021 |
| 520 | a The improvement of experimental models for disorders requires a constant approximation towards the dysregulated tissue. In psychiatry, where an impairment of neuronal structure and function is assumed to play a major role in disease mechanisms and symptom development, this approximation is an ongoing process implicating various fields. These include genetic, animal, and post-mortem studies. To test hypotheses generated through these studies, in vitro models using non-neuronal cells such as fibroblasts and lymphocytes have been developed. For brain network disorders, cells with neuronal signatures would, however, represent a more adequate tissue. Considering the limited accessibility of brain tissue, research has thus turned towards neurons generated from induced pluripotent stem cells as well as directly induced neurons, cerebral organoids, and olfactory neuroepithelium. Regarding the increasing importance and amount of research using these neuronal cells, this review aims to provide an overview of all these models to make sense of the current literature. The development of each model system and its use as a model for the various psychiatric disorder categories will be laid out. Also, advantages and limitations of each model will be discussed, including a reflection on implications and future perspectives. | |
| 700 | 1 | a Millischer, Vu Karolinska Institutet4 aut |
| 700 | 1 | a Wotawa, C4 aut |
| 700 | 1 | a Sawa, A4 aut |
| 700 | 1 | a Lanzenberger, R4 aut |
| 710 | 2 | a Karolinska Institutet4 org |
| 773 | 0 | t The international journal of neuropsychopharmacologyd : Oxford University Press (OUP)g 24:10, s. 759-775q 24:10<759-775x 1469-5111x 1461-1457 |
| 856 | 4 | u https://academic.oup.com/ijnp/article-pdf/24/10/759/40830441/pyab037.pdf |
| 856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:148072930 |
| 856 | 4 8 | u https://doi.org/10.1093/ijnp/pyab037 |
Hitta via bibliotek
- The international journal of neuropsychopharmacology (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
Hitta mer i SwePub
- Av författaren/redakt...
- Unterholzner, J
- Millischer, V
- Wotawa, C
- Sawa, A
- Lanzenberger, R
- Artiklar i publikationen
- The internationa ...
- Av lärosätet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
